Clinical Trials

Showing 1 - 2 of 2 clinical trials matching your search

NCT05058651

S2012, 'Randomized Phase II/III Trial of First Line Platinum/Etoposide with or without Atezolizumab (NSC #783608) in Patients with Advanced or Metastatic Poorly Differentiated Extrapulmonary Neuroendocrine Carcinomas (NEC)' Primary Study Chairs: Drs. D. Zhen, E. Chiorean

This study is currently enrolling.

Associated Conditions: Neuroendocrine

Research Area: Colorado Cancer Research

Research Location: Parker, Colorado
NCT06943755

A Phase 2/3, multicenter, randomized open-label study of zanzalintinib vs everolimus in participants with previously treated, unresectable, locally advanced or metastatic neuroendocrine tumors

This study is currently enrolling.

Associated Conditions: Gastrointestinal

Research Area: Clinical Cancer Research

Research Location: Orlando

An important goal of this study is to evaluate the length of time cancer is not growing or spreading in participants when treated with zanzalintinib compared to everolimus. In addition, this study...